XML 37 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Fair Value Measurement (Tables)
9 Months Ended
Oct. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets that were measured at fair value as of October 31, 2025 and indicates the fair value hierarchy of the valuation (in millions):
DescriptionQuoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Fair Value
Cash equivalents (1):
Time deposits$$1,780 $$1,780 
Money market mutual funds5,592 5,592 
Cash equivalent securities 40 40 
Marketable securities:
Corporate notes and obligations1,441 1,441 
U.S. treasury securities170 170 
Mortgage-backed obligations32 32 
Asset-backed securities645 645 
Municipal securities26 26 
Commercial paper18 18 
Covered bonds
Other12 12 
Strategic investments:
Equity securities68 68 
Total assets$5,660 $4,165 $$9,825 
(1) Included in “cash and cash equivalents” in the accompanying condensed consolidated balance sheets in addition to $1.6 billion of cash, as of October 31, 2025.
The following table presents information about the Company’s assets that were measured at fair value as of January 31, 2025 and indicates the fair value hierarchy of the valuation (in millions):
DescriptionQuoted Prices in
Active Markets
for Identical Assets
(Level 1)
Significant Other
Observable Inputs (Level 2)
Significant
Unobservable
Inputs
(Level 3)
Fair Value
Cash equivalents (1):
Time deposits$$1,698 $$1,698 
Money market mutual funds4,373 4,373 
Cash equivalent securities686 686 
Marketable securities:
Corporate notes and obligations2,557 2,557 
U.S. treasury securities542 542 
Mortgage-backed obligations122 122 
Asset-backed securities1,217 1,217 
Municipal securities107 107 
Commercial paper506 506 
Covered bonds27 27 
Other106 106 
Strategic investments:
Equity securities69 69 
Total assets$4,442 $7,568 $$12,010 
(1) Included in “cash and cash equivalents” in the accompanying condensed consolidated balance sheets in addition to $2.1 billion of cash, as of January 31, 2025.